Professor Kamlesh Khunti, FRCGP, FRCP, MD, PhD, FMedSci

Head of Department and Professor of Primary Care Diabetes andProfessor Kamlesh Khunti Vascular Medicine

Diabetes Research Centre
University of Leicester
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Tel: +44 (0)116 258 4005

Email: kk22@le.ac.uk

For general enquiries, email Raj Gill on rkg4@le.ac.uk or telephone +44 (0)116 258 4005.

Specific Areas of Academic Interest:

  • Diabetes

  • Prevention of Diabetes

  • Risk Assessment Tools

  • Primary Care & Public Health

  • Black Minority Ethnic Health

  • Cardio-Metabolic Diseases

  • Real World Evidence

  • Randomised Controlled Trials

Personal details

NIHR, Senior Investigator Award, 2014

Publications

2019

690. Evaluation and refinement of the PRESTARt tool for identifying 12-14 year olds at high lifetime risk of developing type 2 diabetes compared to a clinicians assessment of risk: a cross-sectional study. BMC Endocrine Disorders (in press)

689.The Microalbuminuria Education Medication and Optimisation (MEMO) study: Four years follow up of multifactorial intervention in high risk individuals with type 2 diabetes (in press)

688Rowlands A, Plekhanova T, Yates T, Mirkes E, Davies M, Khunti K, Edwardson C. A basis for harmonisation of accelerometer physical activity outcomes in epidemiology. Journal for the Measurment of Physical Behaviors 2019 (in press)

687. Rowlands A, Fairclough SJ, Yates T, Edwardson CL, Davies MJ, Munir F, Khunti K, Stiles VH. Activity intensity, volume & norms: Utility & interpretation of accelerometer metrics. Medicine & Science in Sports & Exercise 2019 (in press)

686. 2019 ESC/EASD Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. European Heart Journal (in press)

685. Health inequalities in heart failure: A population-based study of 20-year trends in cause-specific outcomes by gender, socioeconomic status and location of care (in press)

684. Is the increased risk of microvascular and macrovascular complications in South Asians with type 1 diabetes influenced by migration? Results from the UK-India multi-ethnic migration study (in press)

683. Self-management support for people with Type 2 Diabetes: James Lind Alliance priority number (in press)

682. Effect of pragmatic versus explanatory interventions on medication adherence in people with cardiometabolic conditions: a systematic review and meta-analysis (in press)

681. Nicolucci A, Charbonnel B, Gomes MB, Khunti K, Kosiborod M, Shestakova MV, Shimomura, Watada H, Chen H, Cid-Razufa J, Fenici P, Hammar N, Surmont F, Tang F, Pocock S. Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: results from the global DISCOVER study programme. Diabetes Obes Metab. 2019 Jul. DOI: 10.1111/dom.13830. PMID: 31297947

680. Maqbali AA, Brady EM, Davies MJ, Khunti K. The effect of Ramadan fasting on the glycaemic control in patients with Type 2 Diabetes- A systematic review of observational studies (in press)

679. Yadav K, Khunti K, et al. Influence of ethnicity on neonatal outcomes in children born to mothers with diabetes in pregnancy. Diabetic Medicine (in press)

678. Blake H, Narayanasamy M, Batt ME, Khunti K. Effectiveness of Lifestyle Health Promotion Interventions for Nurses: Protocol for a Systematic Review. Journal or Nursing and Practice .2019: 3(1); 81-85.

677. Jones P, Harrison M, Davies M, Khunti K, McCarthy M, Webb D, Berrington R. The biometric shoe: could 3D printed footwear and machine learning theoretically reduce complications from diabetes? The Diabetic Foot Journal. 2019: 22(2); 28-31

676Gulsin G, Kanagala P, Chan DCS, Cheng ASH, Athithan L, Graham-Brown MPM, Singh A, Yang J, LI Z, Khunti K, et al.  Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetes. Therspeutic Advances in Endocrinology and Metabolism. 2019 July. 10:1-17. DOI: 10.1177/2042018819861593 PMID: 31308926

675. Kloecker DE, Zaccardi F, Baldry E, Davies MJ, Khunti K, Webb DR. Efficacy of Low- and Very-Low-Energy Diets in people with Type 2 Diabetes Mellitus: A systematic review and meta-analysis of interventional studies. Diabetes Obes Metab. 2019 Jul: 21(7): 1695-1705. DOI: 10.1111/dom.13727. PMID: 30924575

674. Miksza J, Zaccardi F, Kunutsor S, Seidu S, Davies MJ, Khunti K. Statins and risk of thromboembolism: A meta-regression to disentangle the efficacy-to effectiveness gap using observational and trial evidence. Nutrition, Metabolism and Cardiovascular Diseases.

673. Khunti K, Ji L, Medina J, Surmont F, Kosiborod M. Type 2 diabetes treatment and outcomes worldwide: A short review of the DISCOVER study programme. Diabetes Obes Metab. 2019 Jun. DOI: 10.1111/dom.13817. PMID: 31215715

672. Seidu S, Kunutsor SK, Sesso HD, Gaziano JM, Buring JE, Roncaglioni MC, Khunti K. Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analysIs of randomized controlled trials. Cardiovascular Diabetology. 2019 June:18:70. DOI: 0.1186/s12933-019-0875-4. PMID: 31159806.

671. Rowlands, A, Sherar L, Fairclough S, Yates T, Edwardson CL, Harrington DM, Davies MJ, Munir Fehmidah, Khunti K, Stiles VH. A data-driven, meaningful, easy to interpret, standardised accelerometer outcome variable for global surveillance. Journal of Science and Medicine in Sport. Apr 2019. DOI: 10.1101/604694

670. Meneghini LF, Mauricio D, Orsi E, Lalic NM, Cali AMG, Westerbacka J, Stella P, Candelas Dea C, Pilorget V, Perfetti R, Khunti K, DUNE Investigators. The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting. Diabetes Obes Metab. 2019 Jun: 21(6): 1429 – 1436. DOI: 10.1111/dom.13673. Epub 2019 Mar 28. PMID: 30768845

669. Canivell S, Mata-Cases M, Real J, Franch-Nadal J, Vlacho B, Khunti K, Gratacos M, Mauricio D. Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world setting. Diabetes Obes Metab. 2019 Jun: 21(6): 1373-1380. DOI: 10.1111/dom.13663. Epub 2019 Mar 19. PMID: 30756446

668Jones PJ, Bibb RJ, Davies MJ, Khunti K, McCarthy M, Fong DTP, Erbb D.  A Fitting Problem: Standardising Shoe Fit Standards to Reduce Related Diabetic Foot Ulcers. Diabetes Res Clin Pract. 2019 May: pii: S0168-8227(19)30624-2. DOI: 10.1016/j.diabres.2019.05.017. PMID: 31128134

667. Khunti S, Khunti K, Seidu S. Therapeutic inertia in type 2 diabetes prevalence, causes, consequences and methods to overcome inertia. Ther Ady Endocrinol Metab.. 2019 May 10: 2042018819844694. Doi: 10.1177/2042018819844694. PMID: 31105931

666Tyrer F, Seidu S, Khunti K. Real-world evidence: improving quality in cardiometabolic medicine. Diabetes & Primary Care 2019 May. 21: 47–8.

665. Razieh C, Khunti K, Davies MJ, Edwardson CL, Henson J, Darko N, Comber A, Jones A, Yates T. Association of depression and anxiety with clinical, sociodemographic, lifestyle and environmental factors in South Asians and white Europeans. May 2019. DOI: 10.1111/dme.13986. PMID: 31081286

664. Zaccardi F, Nystrup Husemoen LL, Thorsted BL, Webb DR, Paul SK, Davies MJ, Khunti K. Selectivity of beta-blockers, cardiovascular and all-cause mortality in people with hypoglycaemia: An observational study. Nutr Metab Cardiovasc Dis. 2019 May: 29(5): 481-488. DOI: 10.1016/j.numecd.2019.01.006. PMID: 30940488

663Zaccardi F, Davies MJ, Khunti K, Yates T. Comparative relevance of physical fitness and adiposity on life expectancy: A UK Biobank observational study. 2019 May. DOI: 10.1016/j.mayocp.2018.10.029. Mayo Clin Proc. 2019 May: pii: S0025-6196(19)30063-1. DOI: 10.1016/j.mayocp.2018.10.029. PMID: 31079962

662. Chudasama YV, Khunti K, Zaccardi F, Rowlands A, Yates T, Gillies C, Davies M, Dhalwani N. Physical activity, multimorbidity, and life expectancy: a UK Biobank longitudinal study. BMC Med. 2019 Jun. 17(1):108. DOI:10.1186/s12916-019-1339-0. PMID: 31886007

661. Perrin N, Bodicoat DH, Davies MJ, Robertson N, Snoek FJ, Khunti K. Effectiveness of psychoeducational interventions for the treatment of diabetes-specific emotional distress and glycaemic control in people with type2 diabetes: A systematic review and meta-analysis. Prim Care Diabetes. 2019 Apr: pii: S1751- 9918(19)30145-7. DOI: 10.1016/j.pcd.2019.04.001. PMID: 31040069

660. Chatterjee S,  Khunti K,  Davies MJ. Authors’ Reply to Gough: “Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes”. Drugs. 2019 Apr: 79(6): 683-684. DOI: 10.1007/s40265-019-01093. PMID: 30919304

659. Spanopoulos D, Okhai H, Zaccardi F, Tebboth A, Barrett B, Busse M, Webb J, Khunti K. Temporal variation of renal function in people with type 2 diabetes mellitus: A retrospective UK clinical practice research datalink cohort study. Disbetes Obes Metab. 2019 Apr. DOI: 10.1111/dom.13734. PMID: 30941882

658. Seidu S, Kunutsor SK, Topsever P, Hambling CE, Cos FX, Khunti K. Deintensification in older patients with type 2 diabetes: a systematic review of approaches, rates and outcomes. Diabetes Obes Metab. 2019 Apr. DOI: 10.1111/dom.13724. PMID: 30938038

657. Dhalwani NN, Zaccardi F, Waheed H, Papamargaritis D, Webb DR, Evison F, Lilford R, Davies MJ, Khunti K. Cardiovascular, cancer and mortality events after bariatric surgery in people with and without pre-existing diabetes: A nationwide study. Journal of Diabetes. 2019 Apr: 11(4): 265-272. DOI:10.1111/1753-0407.12851. PMID: 30191659

656. Coles B, Tyrer F, Khunti K. Letter to the Editor: Improving quality in cardiometabolic medicine real-world evidence. Primary Care Diabetes. 2019 Apr: 13(2); 188. DOI: 10.1016/j.pcd.2018.10.002. PMID: 30446359

655. Hussein H, Zaccardi F, Khunti K, Seidu S, Davies MJ, Gray LJ. Cardiovascular efficacy and safety of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a systematic review and network meta-analysis. Diabet Med. 2019 Apr: 36(4): 444-452. DOI: 10.1111/dme.13898. [Epub ahead of print] PMID: 30653708

654. Khunti K, Jung H, Dans A, Held C, Dagenais GR, Yusuf S, Lonn E. Statin Use in Primary Prevention; a Simple Trial Based Approach Compared to Guideline Recommended Risk Algorithms for Selection of Eligible Patients. Canadian Journal of Cardiology Mar 2019. SO828-282X(19); 30188-6. DOI: 10.1016/j.cjca.2019.03.002

653. Rowe C, Sitch AJ, Barratt J, Brettell EA, Cockwell P, Dalton RN, Deeks JJ, Eaglestone G, Pellatt-Higgins T, Kalra PA, Khunti K et al. Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease. Kidney Int. 2019 Mar:  pii: S0085-2538(19)30274-1. DOI: 10.1016/j.kint.2019.02.021. PMID: 31084924

652. Patel P, Gupta P, Burns A, Mohamed AA, Cole R, Lane D, Seidu S, Khunti K. Biochemical Urine Testing of Adherence to Cardiovascular Medications Reveals High Rates of Nonadherence in People Attending Their Annual Review for Type 2 Diabetes. Diabetes Care 2019 Mar. pii: dc181453. DOI: 10.2337/dc18-1453. PMID: 30885952

651. Mohan V, Cooper ME, Matthews DR, Khunti K. The Standard of Care in Type 2 Diabetes: Re-evaluating the Treatment Paradigm. Diabetes Ther. 2019 Mar: 10(Suppl 1):1-13. DOI: 10.1007/s13300-019-0573-y. Epub 2019 Feb 13. PMID: 30758834

650. Pintat S, Fenici P, Hammar N, Ji L, Khunti K et al. Eligibility of patients with type 2 diabetes for sodium–glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study. BMJ Open Diabetes Research and Care. Mar 2019: 7:e000627. DOI: 10.1136/bmjdrc-2018-000627.

649. Gomes MB, Rathmann W, Charbonnel B, Khunti K, Kosiborod M, Nicolucci A, Pocock SJ, Shestakova MV, Shimomura I, Tang F, Watada H, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Surmont F, Ji L; DISCOVER investigators .Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER study. Diabetes Res Clin Pract 2019 Mar. 151:20-32. DOI: 10.1016/j.diabres.2019.03.024. PMID: 30904743

648. Dunkley AJ, Fitzpatrick C, Gray LJ, Waheed G, Heller SR, Frier BM, Davies MJ, Khunti K, Primary Care Diabetes Society. Incidence and severity of hypoglycaemia in type 2 diabetes by treatment regimen: A UK multi-site 12-month prospective observational study. Diabetes, Obes and Metab 2019 Mar. DOI: 10.1111/dom.13690. PMID: 30843327

647. Gulsin GS, Brady EM, Swarbrick DJ, Athithan L, Henson J, Baldry E, Mc Adam J, Marsh AM, PArke KS, Wormleighton JV, Levelt E, Yates T, Bodicoat D, Khunti K, Davies MJ, Mcann GP. Rationale, design and study protocol of the randomised controlled trial: Diabetes Interventional Assessment of Slimming or Training tO Lessen Inconspicuous Cardiovascular Dysfunction (the DIASTOLIC study). BMJ Open. 2019 Mar: 9(3): e023207. DOI: 10.1136/bmjopen-2018-023207 PMID: 30928925

646. Morrison A, Zaccardi F, Khunti K, Davies MJ. Causality between non–alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis. Liver International. 2019 Mar: 39(3): 557-567. DOI: 10.1111/liv.13994. PMID: 30358050

645. Bosch J, O'Donnell MJ, Swaminathan B, Lonn E, Sharma M, Dagenais GR, Diaz R, Khunti K, Lewis B, Avezum A, Held C, Keltai M, Reid C, Toff WD, Dans A, Leiter LA, Sliwa K, Lee SF, Janice M. Pogue, Hart RG, and Yusuf S. Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study. Neurology. 2019 Mar: 92(13): e1435-e1446. DOI: 10.1212/WNL.0000000000007174. PMID: 30814321

644. Khunti K, Seidu S. Therapeutic Inertia and the Legacy of Dysglycemia on the Microvascular and Macrovascular of Diabetes. Diabetes Care. 2019 Mar: 42(3):349-351. DOI: 10.2337/dci18-0030. PMID: 30787057.

643. Kunutsor SK, Seidu S, Khunti K. Response to commentary by Rhew and colleagues on: Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence. Annals of Medicine. 2019 Feb: 51(1): 99-100. DOI: 10.1080/07853890 .2019.1581942. PMID: 30931634

642. Harrington DM, Davies MJ, Bodicoat D, Charles JM, Chudasama YV, Gorely T, Khunti K, Rowlands AV, Sherar LB, Tudor-Edwards R, Yates T, Edwardson CL. A school-based intervention ('Girls Active') to increase physical activity levels among 11- to 14-year-old girls: cluster RCT. Public Health Res. 2019 Feb: 7(5). DOI: 10.3310/phr07050.

641. Kloecker DE, Zaccardi F, Baldry E, Davies MJ, Khunti K, Webb DR. Efficacy of low- and very-low- energy diets in people with type 2 diabetes mellitus: A systematic review and meta-analysis of interventional studies. Diabetes Obes Metab 2019 Mar. DOI: 10.1111/dom.13727. PMID: 30924575

640. Hambling CE, Khunti K, Cos X, Wens J, Martinez L, Topsever P, Del Prato S, Sinclair A, Schernthaner G, Rutten G, Seidy S. Factors influencing safe glucose-lowering in older adults with type 2 diabetes: A Person-centred Approach To Individualised (PROACTIVE) Glycemic Goals for older people A position statement of Primary Care Diabetes Europe. Prim Care Diabetes. 2019 Feb: pii: S1751-9918(18)30300. DOI: 10.1016/j.pcd.2018.12.005. PMID: 30792156

639. Roman M, Monaghan A, Serraino GF, Miller D, Pathak S, Lai F, Zaccardi F, Ghanchi A, Khunti K, Davies MJ, Murphy GJ. Meta-analysis of lifestyle changes for preoperative weight loss on surgical outcomes. British Journal of Surgery. 2019 Feb: 106(3): 181-189. DOI: 10.1002/bjs.11001. PMID: 30328098

638. Khunti K, Seidu S, Davies MJ. Should sodium glucose co-transporter-2 inhibitors be considered as first line oral therapy for people with type 2 diabetes?  Diabetes, Obesity and Metabolism. 2019 Feb: 21(2); 207-209. DOI: 10.1111/dom.13518. PMID: 30178516

637. Holt R, Gossage-Worrall R, Hind D, Bradburn M, McCrone P, Morris T, Edwardson C, Barnard K, Carey M, Davies MJ, Dickens C, Doherty Y, Etherington A, French P, Greenwood K, Kalidindi S, Khunti K, Laugharne R, Pendlebury J, Rathod S, Saxon D, Shiers D, Siddiqi N, Swaby L, Waller G, Wright S.  STEPWISE: Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first episode psychosis: randomised controlled trial. The British Journal of Psychiatry. 2019 Feb: 214(2):63-73. DOI: 10.1192/bjp.2018.167. PMID: 30251622

636. Chatterjee S, Khunti K, Davies MJ. Correction to: Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes. Drugs. 2019 Feb: 79(2): 187. DOI: 10.1007/s40265-019-1063-2. PMID: 30706424

635. Chatterjee S, Khunti K, Davies MJ. Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes. Drugs. 2019 Feb: 79(2): 173-186. DOI: 10.1007/s40265-018-1048-6. PMID: 30623349

634. Woolley AK, Hadjiconstantinou M, Davies MJ, Khunti K, Seidu S. Online patient education interventions in type 2 diabetes or cardiovascular disease: A systematic review of systematic reviews. Prim Care Diabetes. 2019 Feb: 13(1): 16-27. DOI: 10.1016/j.pcd.2018.07.011. PMID: 30131299

633. Thuraisingham S, Chondros P, Catchpool M, Dalziel K, Manski-Nankervis J-A, Speight J, Holmes-Truscott E, Audehm R, Chaing J, Blackberry I, O’Neal D, Khunti K et al. Update on the General Practice Optimising Structured Monitoring to Improve Clinical Outcomes in Type 2 Diabetes (GP-OSMOTIC) trial: statistical analysis plan for a multi-centre randomised controlled trial. Trials. 2019 Jan: 20(1):93. DOI: 10.1186/s13063-018-3126-1. PMID: 30700324

632. Biddle GJH, Edwardson CL, Rowlands AV, Davies MJ, Bodicoat DH, Hardeman W, Eborall H, Sutton S, Griffin S, Khunti K, Yates T. Differences in objectively measured physical activity and sedentary behaviour between white Europeans and south Asians recruited from primary care: cross-sectional analysis of the PROPELS trial. BMC Public Health. 2019 Jan:19(1): 95. DOI: 10.1186/s12889-018-6341-5. PMID: 30665392

2018

631. Abdool M, Khunti K, Seidu S. Healthy eating resources for South Asians. Diabetes & Primary Care. 2018: 20(4): 139-141.

630. Hills AP, Misra A, Gill JMR, Byrne NM, Soares MJ, Ramachandran A, Palaniappan L, Street S, Jayawardena R, Khunti K, Arena R. Public Health and health systems: implications for the prevention of type 2 diabetes in South Asia. Lancet Diabetes Endocrinol. 2018 Dec: 6(12):992-1002. DOI: 10.1016/S2213-8587(18)30203-1. Epub 2018 Oct 1. PMID: 30287104

629. Lawson C, Khunti K. Association of Medication Intensity and Stages of Airflow Limitation With the Risk of Hospitalization or Death in Patients With Heart Failure and Chronic Obstructive Pulmonary. JAMA. 2018 Dec: 1(8); e185489. DOI: 10.1001/jamanetworkopen.2018.5489. PMID: 30646293

628. Misra A, Sattar N, Tandon N, Shrivastava U, Vikram N, Khunti K, Hills AP. Clinical Management of type 2 diabetes in South Asia. The Lancet Diabetes & Endocrinology. 2018 Dec: 6(12): 979-991. DOI: 10.1016/S2213-8587(18)30199-2. Epub 2018 Oct 1. PMID: 30287103

627. Fahami R, Dhalwani N, Khunti K, Davies M, Seidu S. Postpartum monitoring of women with a history of gestational diabetes - A cross-sectional study of an inner-city population. Prim Care Diabetes. 2018 Dec. pii: S1751-9918(18)30155-4. DOI: 10.1016/j.pcd.2018.11.010. [Epub ahead of print]. PMID: 30583931

626. Sukumar N, Dallosso H, Saravanan P, Yates T, Telling C, Shorthose K, Northern A, Schreder S, Brough C, Gray LJ, Davies MJ, Khunti K. Baby Steps - a structured group education programme with accompanying mobile web application designed to promote physical activity in women with a history of gestational diabetes: study protocol for a randomised controlled trial. Trials. 2018 Dec:19(1): 682. DOI: 10.1186/s13063-018-3067-8. PMID: 30541621

625. Lawson CA, Mamas MA, Jones PW, Teece L, McCann G, Khunti K, Kadam UT. Association of Medication Intensity and Stages of Airflow Limitation With the Risk of Hospitalization or Death in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease. JAMA Netw Open. 2018 Dec:1(8): e185489. DOI: 10.1001/jamanetworkopen.2018.5489. PMID: 30646293

624. Khunti K, Danese M, Kutikova L, Catterick D, Sorio-Vilela F, Gleeson M, Seshasai SRK, Brownrigg J. Association of a Combined Measure of Adherence and Treatment Intensity with Cardiovascular Outcomes in Patients with Atherosclerosis or Other Cardiovascular Risk Factors Treated With Statins and/or Ezetimibe. JAMA Netw Open. Dec 2018:1(8): e185554. DOI:10.1001/jamanetworkopen.2018.5554. PMID: 30646277

623. Hills AP, Arena R, Khunti K, Yajnik CS, Jayawardena R, Henry CJ, Street SJ, Soares MJ, Misra A. Epidemiology and determinants of type 2 diabetes in south Asia. The Lancet Diabetes & Endocrinology. 2018 Dec: 6(12); 966-978. DOI: 10.1016/S2213-8587(18)30204-3. PMID: 30287102

622Kosiborod M, Gomes MB, Nicolucci A, Pocock S, Rathmann W, Shestakova MV, Watada H, Shimomura I, Chen H, Cid-Ruzafa J, Fenici P, Hammar N, Surmont F, Tang F, Khunti K, DISCOVER invevrstogators. Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovasc Diabetol. 2018 Nov: 17(1): 150. DOI: 10.1186/s12933-018-0787-8. PMID: 30486889

621. Hussein H, Zaccardi F, Dhalwani NN, Davies MJ, Khunti K,Gray LJ. Efficacy and safety of sodium- glucose cotransporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1Ras) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol. BMJ Open. 2018 Nov: 8(11): e023206. DOI:10.1136/bmjopen-2018-023206. PMID: 30413509

620. Holt R I, Hind D, Gossage-Worrall R, Bradburn M J, Saxon D, McCrone P, Morris T A, Etherington A, Shiers D, Barnard K, Swaby L, Edwardson C, Carey M E, Davies M J, Dickens C M, Doherty Y, French P, Greenwood K E, Kalidindi S, Khunti K, Laugharne R, Pendlebury J, Rathod S, Siddiqi N, Wright S, Waller G, Gaughran F, Barnett J & Northern A. Structured lifestyle education to support weight loss for people with schizophrenia, schizoaffective disorder and first episode psychosis: the STEPWISE RCT. A structured lifestyle education programme for people with schizophrenia did not affect weight change after 12 months. Health Technology Assessment. 2018 Nov: 22(65): 1-160. DOI: 10.3310/hta22650. PMID: 30499443

619. Jadawji C, Crasto W, Gillies C, Kar D, Davies MJ, Khunti K, Seidu S. Prevelance and progression of diabetic nepropathy in South Asian, White European and African Caribbean people with type 2 diabetes: A systematic review and meta-analysis. Diabetes Obes Metab. 2018 Nov: 21:658–673. DOI: 10.1111/dom.13569. PMID: 30407709

618. Leiter LA, Cheng AYY, Ekoé JM, Goldenberg RM, Harris SB, Hramiak IM, Khunti K, Lin PJ, Richard JF, Senior PA, Yale JF, Goldin L, Tan MK, Langer A. Glycated Hemoglobin Level Goal Achievement in Adults With Type 2 Diabetes in Canada: Still Room for Improvement. Can J Diabetes. 2018 Nov. pii: S1499-2671(18)30370-8. DOI: 10.1016/j.jcjd.2018.10.005. [Epub ahead of print] PMID: 30554985

617. Tyrer F, Dunkley AJ, Singh J, Kristunas C, Khunti K, Bhaumik S, Davies MJ, Yates TE, Gray LJ. Multimorbidity and lifestyle factors among adults with intellectual disabilities: a cross-sectional analysis of a UK cohort. J Intellect Disabil Res. 2018 Nov. DOI: 10.1111/jir.12571. [Epub ahead of print]. PMID: 30485584 DOI:10.1111/jir.12571. PMID: 30485584

616. Cosentino F, Ceriello A, Baeres FMM, Fioretto P, Garber A, Stough WG, George JT, Grant PJ, Khunti K, Plutzky AMLJ, Ryden L, Scheen A, Standl E, Tuomilehto J, Zannad F. Addressing Cardiovascular Risk in Type 2 Diabetes Mellitus: A Report from the European Society of Cardiology Cardiovascular Roundtable. European Heart Jounral. 2018 Nov. DOI: 10.1093/eurheartj/ehy677. PMID: 30445605

615. Blonde L, Khunti K, Harris SB, Meizinger C, Skolnik NS. Interpretation and Impact of Real-World Clinical Data for the Practising Clinician. Advances in Therapy. 2018 Nov: 35(11); 1763-1774. DOI: 10.1007/s12325-018-0805-y. PMID: 30357570

614. Van Schoonhoven AV, Van Asselt ADI, Tomaszewski M, Patel P, Khunti K, Gupta P, Postma MJ. Cost-utility of an objective biochemical measure to improve adherence to antihypertensive treatment. Hypertension. 2018 Nov: 75(5):1117-1124. DOI: 10.1161/HYPERTENSIONAHA.118.11227. PMID: 30354817

613. Pedersen-Bjergaard U, Alsifri S, Aronson R, Berković MC, Galstyan G, Gydesen H, Lekdorf JB, Ludvik B, Moberg E, Ramachandran A, Khunti K. Comparison of the HAT study, the largest global hypoglycaemia study to date, with similar large real-world studies. Diabetes Obes Metab. 2018 Nov: DOI: 10.1111/dom.13588. [Epub ahead of print] PMID:30456887

612. Hussein H, Zaccardi F, Dhalwani NN, Davies MJ, Khunti K, Gray LJ. Efficacy and safety of sodium-glucose co-transporter 2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes: a systematic review and network meta-analysis study protocol. BMJ Open. 2018 Nov: 8(11): e023206. DOI: 10.1136/bmjopen-2018-023206. PMID: 30413509

611. Zaccardi F, Khunti K. Glucose dysregulation phenotypes – time to improve outcomes. Nature Reviews Endocrinology. 2018 Nov: 14(11): 632-633. DOI: 10.1038/s41574-018-0092-3. PMID: 30202117

610. Yates T, Edwardson E, Celis-Morales C, Biddle S, Davies MJ, Esliger D, Henson J, Kazi A, Khunti K, Sattar N, Sinclair AJ, Rowlands A, Velayudhan L, Zaccardi F, Gill JMR. Metabolic effects of breaking-up prolonged sitting with standing or self-paced walking on postprandial metabolism in older South Asians and White Europeans: a randomized acute study. J Gerontol A Biol Sci Med Sci. 2018 Nov. DOI: 10.1093/gerona/gly252. [Epub ahead of print] PMID: 30403772

609. Cousminer DL, Ahlqvist E, Mishra R, Andersen MK, Chesi A, Hawa M, Davis A, Hodge KM, Bradfield JP, Zhou K, Guy VC, Åkerlund M, Wod M, Fritsche GL, Vestergaard H, Snyder J, Højlund K, Linneberg A, Käräjämäki A, Brandslund I, Kim CE, Witte D, Sørgjerd EP, Brillon DJ, Pedersen O, Beck-Nielsen H, Grarup N, Pratley RE, Rickels MR, Vella A, Ovalle F, Melander O, Harris RL, Varvel S, Grill VER, Bone Mineral Density in Childhood Study, Hakonarson H, Froguel P, Lonsdale JT, Mauricio D, Schloot NC, Khunti K, Greenbaum CJ, Åsvold BO, Yderstræde BK, Pearson EP, Schwartz S, Voight BF, Hansen T, Tuomi T, Boehm BO, Groop L, Leslie DR and Grant SFA.  First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes. Diabetes Care. 2018 Nov: 41(11): 2396-2403. DOI: 10.2337/dc18-1032. PMID: 30254083

608. Herring LY, Dallosso H, Chatterjee S, Bodicoat D, Schreder S, Khunti K, Yates T, Seidu S, Hudson I, Davies MJ. Physical Activity after Cardiac EventS (PACES) – a group education programme with subsequent text-message support designed to increase physical activity in individuals with diagnosed coronary heart disease: Study protocol for a randomised controlled trial. Trials. Oct 2018: 19(1): 537. DOI: .org/10.1186/s13063-018-2923-x. PMID: 30286797

607. Biddle G, Edwardson CL, Henson J, Davies MJ, Khunti K, Rowlands A, Yates T.  Associations of physical behaviours and behavioural reallocations with markers of metabolic health: a compositional data analysis. Int. J. Environ. Res. Public Health. 2018 Oct:15(10): E2280. DOI:10.3390/ijerph15102280. PMID: 30336601

606. Nauck M, Araki A, Hehnke U, Plat A, Clark D, Khunti K. Risk of hypoglycaemia in people aged ≥65 years receiving linagliptin: pooled data from 1489 individuals with type 2 diabetes mellitus. International Journal of Clinical Practice. 2018 Oct: 72(10):e13240. DOI: 10.1111/ijcp.13240. PMID: 30216648

605. Khunti K, Chatterjee S, Gerstein HC, Zoungas S, Davies MJ. Do sulphonylureas still have a place in clinical practice? The Lancet Diabetes and Endocrinology. 2018 Oct: 6(10): 821-832. DOI: 10.1016/S2213-8587(18)30025-1. PMID: 29501322

604. P. Gupta, Mohamed AA, Patel P, Burns A, Saeed M, Lane D, Seidu S, Khunti K. High rates of non-adherence to antidiabetic, antihypertensive and lipid lowering treatment in patients with Type 2 diabetes revealed by liquid chromatography-tandem mass spectrometry urine analysis. Atherosclerosis. 2018 Sep: 34; e1-e2. DOI: 10.1016/j.atherosclerosissup.2018.007.021.

603. Kunutsor SK, Seidu S, Khunti K. Depression, antidepressant use, and risk of venous thromboembolism: systematic review and meta-analysis of published observational evidence. Ann Med. 2018 Sep: 50(6): 529-537. DOI: 10.1080/07853890.2018.1500703 PMID: 30001640

602. Desai U, Kirson NY, Kim J, Khunti K, King S, Trieschman E, Hellstern M, Hunt PR, Mukherjee J. Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes. Diabetes Care. 2018 Aug 21. pii: dc170662. doi: 10.2337/dc17-0662. PMID: 30131396

601. Woolley AK, Hadjiconstantinou M, Davies MJ, Khunti K, Seidu S. Online patient education interventions in type 2 diabetes or cardiovascular disease: A systematic review of systematic reviews. Prim Care Diabetes. 2018 Aug 18. pii: S1751-9918(18)30233-X. doi: 10.1016/j.pcd.2018.07.011. PMID: 30131299

600. Dhalwani NN, Zaccardi F, Davies MJ, Khunti K. Body mass index and mortality in people with and without diabetes: a UK Biobank study. Nutrition, Metabolism & Cardiovascular Diseases.  DOI: 10.1016/j.numecd.2018.07.007 [Epub 2018 Jul 29]. PMID: 30309720

599. Wilding J, Godec T, Khunti K, Pocock S, Fox R, Smeeth L, Clauson P, Fenici P, Hammar N, Medina J. Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second- line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Datalink. BMC Medicine. 2018 July 16; 16(1):116. DOI: 10.1186/s12916-018-1085-8. PMID: 30008267

598. Furler J, O’Neal DN, Speight J, Blackberry I, Manski-Nankervis J, Thuraisingam S, de Le Rue K, Ginnivan L, Browne JL, Holmes-Truscott E, Khunti K, Dalziel K, Chiang J, Audehm R, Kennedy M, Clark M, Jenkins A, Liew D, Clarke P, Best J. The GP-OSMOTIC trial protocol: an individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice. BMJ Open. 2018 July; 8(7):e021435. doi:10.1136/bmjopen-2017-021435 PMID: 30010897

597. Willis A, Crasto W, Gray LJ, Dallosso H, Waheed G, Gray G, Davies MJ, Khunti K. The General Practitioner Prompt Study to Reduce Cardiovascular and Renal Complications in Patients With Type 2 Diabetes and Renal Complications: Protocol and Baseline Characteristics for a Cluster Randomized Controlled Trial. JMIR Res Protoc. 2018 Jun 8;7(6):e152. doi: 10.2196/resprot.9588. PMID: 29884609

596. Owusu ESA, Samanta M, Shaw JE, Majeed A, Khunti K, Paul SK. Weight loss and mortality risk in patients with different adiposity at diagnosis of type 2 diabetes: a longitudinal cohort study. Nutr Diabetes. 2018 Jun 1;8(1):37. doi: 10.1038/s41387-018-0042-0. PMID: 29855473

595. Thuresson M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland K, Jørgensen ME, Wittbrodt E, Hammar N, Fenici P, Kosiborod M; CVD-REAL Investigators and Study Group. Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10. Diabetes Care. 2018 Jun; 41(6):e106-e108. doi: 10.2337/dc18-0338. PMID: 29784708

594. Cavender MA, Norhammar A, Birkeland K, Jørgensen ME, Wilding JP, Khunti K, Fu A, Bodegård J, Blak BT, Wittbrodt E, Thuresson M, Fenici P, Hammar N, Kosiborod M; CVD-REAL Investigators and Study Group. SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL. Journal of American College of Cardiology. 2018 June; 71(22):2497-2506. doi: 10.1016/j.jacc.2018.01.085. PMID: 29852973

593. Feher MD, Munro N, Russell-Jones D, de Lusignan S, Khunti K. Novel diabetes subgroups. Lancet Diabetes Endocrinol. 2018 Jun;6(6):439. doi: 10.1016/S2213-8587(18)30126-8. PMID: 29803263

592. Sathanapally H, Khunti K, Kadam U, Seidu S. Shared decision making in multimorbidity. Aust J Gen Pract. 2018 Jun;47(6):397-398. PMID: 29966187

591. Zemedikun DT, Gray LJ, Khunti K, Davies MJ, Dhalwani NN. Patterns of multimorbidity in middle-age and older adults: An analysis of the UK Biobank data. Mayo Clinic Proceedings. 2018 Jul;93(7):857-866. doi: 10.1016/j.mayocp.2018.02.012. [Epub 2018 May 22]. PMID: 29801777

590. Owusu Adjah ES, Bellary S, Hanif W, Patel K, Khunti K, Paul SK. Prevalence and incidence of complications at diagnosis of T2DM and during follow-up by BMI and ethnicity: a matched case-control analysis. Cardiovasc Diabetol. 2018 May 15;17(1):70. doi: 10.1186/s12933-018-0712-1. PMID: 29764436

589. Fitzpatrick C, Chatterjee S, Seidu S, Bodicoat DH, Ng GA, Davies MJ, Khunti K. Association of hypoglycaemia on cardiac arrhythmia risk in patients with diabetes mellitus: A systematic review and meta-analysis. Diabetes Obes Metab. 2018 May 8. doi: 10.1111/dom.13348. PMID: 29740922

588. Khunti K, Gavin JR, Boulton AJM, Blickstead R, McGill M, Ceriello A, Raz I, Sadikot S, Wood DA, Cos X, Kalra S, Das AK, Espinosa López C; Berlin Declaration Steering Group. The Berlin Declaration: A call to improve early actions related to type 2 diabetes. Why is primary care important? Prim Care Diabetes. 2018 May 8. pii: S1751-9918(18)30076-7. doi: 10.1016/j.pcd.2018.04.003. PMID: 29752222

587. Bridgwood B, Lager KE, Mistri AK, Khunti K, Wilson AD, Modi P. Interventions for improving modifiable risk factor control in the secondary prevention of stroke. Cochrane Database Syst Rev. 2018 May 7;5:CD009103. doi: 10.1002/14651858.CD009103.pub3. PMID: 29734470

586. Khunti K, Cigrovski Berković M, Ludvik B, Moberg E, Barner Lekdorf J, Gydesen H, Pedersen-Bjergaard U. Regional variations in definitions and rates of hypoglycaemia: findings from the global HAT observational study of 27 585 people with Type 1 and insulin-treated Type 2 diabetes mellitus. Diabetic Medicine. 2018 May 5. doi: 10.1111/dme.13662. PMID: 29729048

585. Zaccardi F, Dhalwani NN, Webb DR, Davies MJ, Khunti K. Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates. Diabetologia. 2018 Jul;61(7):1592-1602. doi: 10.1007/s00125-018-4626-y. [Epub 2018 May 1] PMID: 29717336

584. Harrington DM, Davies MJ, Bodicoat DH, Charles JM, Chudasama Y, Gorely T, Khunti K, Plekhanova T, Rowlands AV, Shearer L, Tudor Edwards R, Yates T, Edwardson CL. Effectiveness of the ‘Girls Active’ school-based physical activity programme: A cluster randomised controlled trial. International Journal of Behavioral Nutrition and Physical Activity. 2018 Apr 25;15(1):40. doi: 10.1186/s12966-018-0664-6. PMID: 29695250

583. Kosiborod M, Birkeland KI, Cavender M, Fu A, Wilding J, Khunti K, Holl R, Norhammar A, Jørgensen M, Wittbrodt E, Thuresson M, Bodegård J, Hammar N, Fenici P, CVD-REAL Investigators and Study Group. Rates of myocardial infarction and stroke in patients initiated on SGLT2-inhibitors versus other glucose-lowering agents in real-world clinical practice: results from the CVD-REAL study. Diabetes, Obesity and Metabolism. 2018 Aug;20(8):1983-1987. doi: 10.1111/dom.13299. [Epub 2018 Apr 17] PMID: 29569378

582. Khunti K, Seidu S. Diabetes research in primary care: Fiction, reality or essential? Diabet Med. 2018 Jul;35(7):832-834. doi: 10.1111/dme.13638. [Epub 2018 Apr 13]. PMID: 29653466

581. Mani H, Levy MJ, Khunti K. Polycystic Ovary Syndrome; an underestimated problem in primary care (Letter). International Journal of Clinical Practice. 2018 Apr;72(4):e13081. doi: 10.1111/ijcp.13081. PMID: 29878477

580. Griffin SJ, Bethel MA, Holman RR, Khunti K, Wareham N, Brierley G, Davies MJ, Dymond A, Eichenberger R, Evans P, Gray A, Greaves C, Harrington K, Hitman G, Irving G, Lessels S, Millward A, Petrie JR, Rutter M, Sampson M , Sattar N, Sharp S. Metformin in non-diabetic hyperglycaemia: the GLINT feasibility RCT. Health Technol Assess. 2018 Apr;22(18):1-64. doi: 10.3310/hta22180. PMID: 29652246

579. Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes - Authors' reply. Lancet. 2018 Mar 31;391(10127):1262. doi: 10.1016/S0140-6736(18)30609-3. PMID: 29619960

578. Ceriello A, Gavin III JR, Boulton AJM, Blickstead R, McGill M, Raz I, Sadikot S, Wood DA, Cos X, Khunti K, Kalra S, Das AK, López CE, on behalf of the Berlin Declaration Steering Group. The Berlin Declaration: A call to action to improve early actions related to type 2 diabetes. How can specialist care help? Diabetes Research and Clinical Practice. 2018 May; 139: 392-399. doi.org/10.1016/j.diabres.2018.03.037. [Epub 2018 Mar 27] PMID: 29596943

577. White WB, Heller SR, Cannon CP, Howitt H, Khunti K, Bergenstal RM; EXAMINE Investigators. Alogliptin in Patients with Type 2 Diabetes Receiving Metformin and Sulfonylurea Therapies in the EXAMINE Trial. Am J Med. 2018 Jul;131(7):813-819.e5. doi: 10.1016/j.amjmed.2018.02.023. [Epub 2018 Mar 23] PMID: 29581078

576. Kosiborod M, Lam CSP, Kohsaka S, Kim DJ, Karasik A, Shaw J, Tangri N, Goh SY, Thuresson M, Chen H, Surmont F, Hammar N, Fenici P, Khunti K; CVD-REAL Investigators and Study Group. Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study. J Am Coll Cardiol. 2018 Jun 12;71(23):2628-2639. doi: 10.1016/j.jacc.2018.03.009. [Epub 2018 Mar 11]. PMID: 29540325

575. Khunti K, Kosiborod M, Ray KK. Legacy benefits of blood glucose, blood pressure and lipid control in people with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia? Diabetes Obes Metab. 2018 Jun;20(6):1337-1341. doi: 10.1111/dom.13243. [Epub 2018 Mar 11]. PMID: 29405543

574. Brady EM, Bodicoat DH, Hall AP, Khunti K, Yates T, Edwardson CL, Davies MJ. Sleep duration, obesity and insulin resistance in a multi-ethnic UK population at high risk of diabetes. Diabetes Res Clin Pract. 2018 May;139:195-202. doi:10.1016/j.diabres.2018.03.010. [Epub 2018 Mar 9]. PMID: 29526681

573. Zaccardi F, Kunutsor SK, Seidu S, Davies MJ, Khunti K. Is the lower risk of venous thromboembolism with statins related to low-density-lipoprotein reduction? A network meta-analysis and meta-regression of randomised controlled trials. Atherosclerosis. 2018 Apr;271:223-231. doi: 10.1016/j.atherosclerosis.2018.02.035. [Epub 2018 Mar 2]. PMID: 29524865

572. Edwardson CL, Davies MJ, Khunti K, Yates T, Rowlands AV. Steps per day measured by consumer activity trackers worn at the non-dominant and dominant wrist relative to a waist-worn pedometer. Journal for the Measurement of Physical Behaviour. 2018 March; 1(1): 2-8. doi.org/10.1123/jmpb.2017-0001

571. Khunti K, Chatterjee S, Gerstein HC, Zoungas S, Davies MJ. Do sulphonylureas still have a place in clinical practice? The Lancet Diabetes and Endocrinology. 28 Feb 2018. doi.org/10.1016/S2213-8587(18)30025-1. PMID: 29501322

570. Kosiborod M, Cavender M, Fu A, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen ME, Thuresson M, Arya N, Bodegård J, Hammar N, Fenici P; CVD-REAL Investigators and Study Group. Response by Kosiborod et al to Letters Regarding Article, “Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study". Circulation. 27 Feb 2018; 137(9): 989-991. doi.org/10.1161/CIRCULATIONAHA.117.031847. PMID: 29483180

569. Seidu S, Kunutsor S, Cos X, Gillani S, Khunti K, for and on behalf of Primary Care Diabetes Europe. SGLT2 inhibitors and renal outcomes in people type 2 diabetes with or without renal impairment: a systematic review and meta-analysis. Primary Care Diabetes. 2018 Jun;12(3):265-283. doi: 10.1016/j.pcd.2018.02.001. [Epub 2018 Feb 24]. PMID: 29482993

568. Rowlands AV, Harrington DM, Bodicoat DH, Davies MJ, Sherar LB, Gorely T, Khunti K, Edwardson CL. Compliance of Adolescent Girls to Repeated Deployments of Wrist-worn Accelerometers. Med Sci Sports Exerc. 2018 Jul;50(7):1508-1517. doi: 10.1249/MSS.0000000000001588. [Epub 23 Feb 2018]. PMID: 29474208

567. Chatterjee S, Davies MJ, Stribling B, Farooqi A, Khunti K. Real-world evaluation of the DESMOND type 2 diabetes education and self management programme. Practical Diabetes. 2018 Feb 8; 35(1): 19-22. doi: 10.1002/pdi.2154

566. Chatterjee S, Davies MJ, Khunti K. What have we learnt from "real world" data, observational studies and meta-analyses. Diabetes Obes Metab. 2018 Feb;20 Suppl 1:47-58. doi: 10.1111/dom.13178. PMID: 29364585

565. Chatterjee S, Davies MJ, Heller S, Speight J, Snoek FJ, Khunti K. Technology and chronic disease management - Authors' reply. Lancet Diabetes Endocrinol. 2018 Feb;6(2):91-92. doi: 10.1016/S2213-8587(17)30440-0. PMID: 29413163

564. Rowlands AV, Mirkes EM, Yates T, Clemes S, Davies MJ, Khunti K, Edwardson CL. Accelerometer assessed physical activity in epidemiology: Are monitors equivalent? Med Sci Sports Exerc. 2018 Feb; 50(2):257-265. doi: 10.1249/MSS.0000000000001435. PMID: 28976493

563. Aronson R, Galstyan G, Goldfracht M, Al Sifri S, Elliott L, Khunti K. Direct and indirect health economic impact of hypoglycaemia in global population of patients with insulin-treated diabetes. Diabetes Res Clin Pract. 2018 Apr;138:35-43. doi: 10.1016/j.diabres.2018.01.007. [Epub 2018 Jan 31]. PMID: 29355651

562. Rowlands AV, Edwardson CL, Davies MJ, Khunti K, Harrington DM, Yates T. ‘Beyond Cut-points: Accelerometer Metrics that Capture the Physical Activity Profile. Med Sci Sports Exerc. 2018 Jun;50(6):1323-1332. doi: 10.1249/MSS.0000000000001561. [Epub 2018 Jan 23] PMID: 29360664

561. Khunti K, Ceriello A, Cos X, De Block C. Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: a meta-analysis. Diabetes Research and Clinical Practice. 2018 Mar;137:137-148. doi: 10.1016/j.diabres.2017.12.004. [Epub 2018 Jan 8]. PMID: 29325774

560. Joseph P, Lonn E, Bosch J, Lopez P, Zhu J, Keltai M, Dans A, Reid C, Khunti K, Toff W, Piegas L, Kim JH, Swaminathan B, Bohm M, Yusuf S; HOPE-3 Investigators. Long-term Effects of Statins, Blood Pressure-Lowering, and Both on Erectile Function in Persons at Intermediate Risk for Cardiovascular Disease: A Substudy of the Heart Outcomes Prevention Evaluation-3 (HOPE-3) Randomized Controlled Trial. Can J Cardiol. 2018 Jan;34(1):38-44. doi: 10.1016/j.cjca.2017.09.026. PMID: 29275880

559. Henson J, Edwardson CL, Morgan B, Horsfield M, Khunti K, Davies MJ, Yates T. Sedentary time and MRI derived measures of adiposity in active vs. inactive patients. Obesity (Silver Spring). 2018 Jan; 26(1): 29-36. doi: 10.1002/oby.22034. PMID: 29265769

2017

558. Schernthaner G, Khunti K, Lotan C, Burnier M, Drexel H, Prazny M. Relevance of positive cardiovascular outcome trial results in clinical practice: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes (ACROSST2D). Dove Press. 13 Dec 2017; 13:1569-1576. doi.org/10.2147/TCRM.S144362. PMID: 29276388

557. Zaccardi F, Dhalwani NN, Dales J, Mani H, Khunti K, Davies MJ, Webb D. Comparison of glucose-lowering agents following dual therapy failure in type 2 diabetes, Systematic review and network meta–analysis of randomised controlled trials. Diabetes, Obesity and Metabolism. 2018 Apr;20(4):985-997. doi: 10.1111/dom.13185. [Epub 2017 December 5]. PMID: 29205774

556. Jelleyman C, Edwardson CL, Henson J, Gray LJ, Rowlands AV, Khunti K, Davies MJ, Yates T. Associations of Physicial Activity Intensities with Markers of Insulin Sensitivity. Medicine & Science in Sports & Exercise. 2017 Dec;49(12):2451-2458. doi: 10.1249/MSS.0000000000001381. PMID: 28723844

555. Webb M, Davies MJ, Ashra N, Bodicoat D, Brady E, Webb D, Moulton C, Ismail K, Khunti K. The association between depressive symptoms and insulin resistance, inflammation and adiposity in men and women. PloS One. 12(11):e0187448. 2017 Nov 30. doi: 10.1371/journal.pone.0187448. PMID: 29190710

554. Yates T, Bakrania K, Zaccardi F, Dhalwani N, Hamer M, Davies MJ, Khunti K. Reaction time, cardiorespiratory fitness and mortality in UK Biobank: An observational study. Intelligence. 66, January–February 2018; 79-83. [Epub 23 Nov 2017] doi.org/10.1016/j.intell.2017.11.006

553. Khunti K, Kosiborod M. Sodium-glucose co-transporter-2 inhibitors and cardiovascular outcome studies in people with type 2 diabetes: From efficacy to effectiveness. Diabetes, Obesity and Metabolism. 2018 Apr;20(4):763-765. doi: 10.1111/dom.13142. [Epub 2017 Nov 22]. PMID: 29077267

552. Russell-Jones D, Pouwer F, Khunti K. Identification of barriers to insulin therapy and approaches for overcoming them. Diabetes Obes Metab. 2018 Mar;20(3):488-496. doi: 10.1111/dom.13132. [Epub 2017 Nov 22]. PMID: 29053215

551. Henson J, Edwardson CL, Bodicoat DH, Bakrania K, Davies MJ, Khunti K, Talbot DCS, Yates T. Reallocating sitting time to standing or stepping through isotemporal analysis: associations with markers of chronic low-grade inflammation. J Sports Sci. 2018 Jul;36(14):1586-1593. doi: 10.1080/02640414.2017.1405709. [Epub 2017 Nov 21]. PMID: 29157133

550. Mani H, Chudasama Y, Hadjiconstantinou M, Bodicoat DH, Edwardson C, Levy M, Gray LJ, Barnett J, Daly H, Howlett T, Khunti K, Davies MJ. Structured Education programme for women with polycystic ovary syndrome: A randomised controlled trial. Endocr Connect. 2018 Jan;7(1):26-35. doi: 10.1530/EC-17-0274. [Epub 2017 Nov 13]. PMID: 29133383

549. Routen A, Biddle S, Bodicoat D, Cale L, Clemes S, Edwardson C, Glazebrook C, Harrington D, Khunti K, Pearson N, Salmon J, Sherar L. Study design and protocol for a mixed methods evaluation of an intervention to reduce and break up sitting time in primary school classrooms in the UK: The CLASS PAL (Physically Active Learning) Programme. BMJ Open. 8 Nov 2017; 7:e019428. DOI: 10.1136/bmjopen-2017-019428. PMID: 29122808

548. McCarthy M, Edwardson CL, Davies MJ, Henson J, Bodicoat DH, Khunti K, Dunstan DW, King JA, Yates T. Fitness Moderates Glycemic Responses to Sitting and Light Activity Breaks. Med Sci Sports Exerc. 2017 Nov;49(11):2216-2222. doi: 10.1249/MSS.0000000000001338. PMID: 28594657

547. Danese M, Kuitkova L, Catterick D, Sorio-Vilela F, Gleeson M, Khunti K, Seshasai SR, Brownrigg J, Ray KK. Characteristics And Risk Factor Burden Of Patients Receiving Lipid Modifying Therapy In The United Kingdom. Value in Health. Oct-Nov 2017; 20(9): A605-A606. doi.org/10.1016/j.jval.2017.08.1175

546. Zaccardi F, Khunti K. Diabetes: Predicting severe hypoglycaemia - a step forward. Nat Rev Endocrinol. 2017 Dec;13(12):692-693. doi: 10.1038/nrendo.2017.138. [Epub 2017 Oct 23] PMID: 29052593

545. Chatterjee S, Davies MJ, Khunti K. How to improve long-term glycemic control in the real world. Medicographia 2017; 132, 39(3): 167-176.

544. Dhalwani NN, Fahami R, Sathanapally H, Seidu S, Davies MJ, Khunti K. Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ Open. 2017 Oct 16;7(10):e016358. doi: 10.1136/bmjopen-2017-016358. PMID: 29042378

543. Jones P, Davies MJ, Khunti K, Seidu S, Chatterjee S. Artificial Neural Networks in Diabetes Healthcare Professional Education - Effective Diabetes Education Now (EDEN). Practical Diabetes. 2017 Oct 13; 34(8): 268-270 doi: 10.1002/pdi.2134.

542. Lawson C, Jones P, Teece L, Dunbar S, Seferovic P, Khunti K, Mamas M, Kadam U. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification. JACC Heart Fail. 2018 Jan;6(1):18-26. doi: 10.1016/j.jchf.2017.08.020. [Epub 2017 Oct 11]. PMID: 29032131

541. Khunti K, Davies MJ. Clinical inertia versus overtreatment in glycaemic management. The Lancet Diabetes and Endocrinology. 2018 Apr;6(4):266-268. doi: 10.1016/S2213-8587(17)30339-X. [Epub 2017 Oct 9]. PMID: 29033057

540. Seidu S, Than T, Kar D, Lamba A, Brown P, Zafar A, Hussain R, Amjad A, Capehorn M, Martin E, Fernando K, McMoran J, Millar-Jones D, Kahn S, Campbell N, Brice R, Mohan R, Mistry M, Kanumilli N, St. John J, Quigley R, Kenny C, Khunti K. Therapeutic inertia amongst general practitioners with interest in diabetes. Prim Care Diabetes. 2018 Feb;12(1):87-91. doi: 10.1016/j.pcd.2017.09.001. [Epub 2017 Oct 6] PMID: 28993141

539. Khunti K, Gomes M, Pocock S, Shestakova M, Pintat S, Fenici P, Hammar N, Medina J. Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: a systematic review. Diabetes Obes Metab. 2018 Feb; 20(2):427-437. doi: 10.1111/dom.13088. [Epub 2017 Oct 1]. PMID: 28834075

538. Chatterjee S, Davies MJ, Heller S, Speight J, Snoek FJ, Khunti K. Diabetes stuctured self-management education programmes: a narrative review and current innovations. Lancet Diabetes Endocrinol. 2018 Feb;6(2):130-142. doi: 10.1016/S2213-8587(17)30239-5. [Epub 2017 Sep 29]. PMID: 28970034

537. Khunti K, Godec TR, Medina J, Garcia-Alvarez L, Hiller J, Gomes MB, Cid-Ruzafa J, Charbonnel B, Fenici P, Hammar N, Hashigami K, Kosiborod M, Nicolucci A, Shestakova MV, Ji L, Pocock S. Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany. Diabetes Obes Metab. 2018 Feb;20(2):389-399. doi: 10.1111/dom.13083. [Epub 2017 Sep 28] PMID: 28817227

536. Arnold SV, Inzucchi S, Tang F, McGuire D, Mehta S, Maddox T, Goyal A, Sperling L, Einhorn D, Wong N, Khunti K, Lam C, Kosiborod M. Real-world use and modeled impact of glucose-lowering therapies evaluated in recent cardiovascular outcomes trials: An NCDR® Research to Practice project. Eur J Prev Cardiol. 2017 Oct 1;24(15):1637-1645. doi: 10.1177/2047487317729252. [Epub 2017 Sep 5]. PMID: 28870145

535. Perrin NE, Davies MJ, Robertson N, Snoek FJ, Khunti K. The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis. Diabetic Medicine. 2017 Nov;34(11):1508-1520. doi: 10.1111/dme.13448. [Epub 2017 Aug 31]. PMID: 28799294

534. Yates T, Zaccardi F, Dhalwani NN, Davies MJ, Bakrania K, Celis-Morales C, Gill JMR, Franks PW, Khunti K. Association of walking pace and handgrip strength with all-cause, cardiovascular, and cancer mortality: A UK Biobank observational study. European Heart Journal. 2017 Nov 14;38(43):3232-3240. doi: 10.1093/eurheartj/ehx449. [Epub 2017 Aug 21]. PMID: 29020281

533. Barber SR, Dhalwani NN, Davies MJ, Khunti K, Gray LJ. External National Validation of the Leicester Self-Assessment Score for Type 2 Diabetes Using Data from the English Longitudinal Study of Ageing. Diabet Med. Nov;34(11):1575-1583. doi: 10.1111/dme.13433. [Epub 2017 Aug 20.]. PMID: 28744894

532. Khunti K, Seidu S, Kunutsor S, Davies MJ. Association Between Adherence to Pharmacotherapy and Outcomes in Type 2 Diabetes: A Meta-analysis. Diabetes Care. 2017 Nov;40(11):1588-1596. doi: 10.2337/dc16-1925. [Epub 2017 Aug 11]. PMID: 28801474

531. Arnold SV, Goyal A, Inzucchi SE, McGuire DK, Tang F, Mehta SN, Sperling LS, Maddox TM, Einhorn D, Wong ND, Hammar N, Fenici P, Khunti K, Lam CSP, Kosiborod M. Quality of Care of the Initial Patient Cohort of the Diabetes Collaborative Registry®. Journal of American Heart Association. 2017 Aug 11;6(8). pii: e005999 doi:10.1161/JAHA.117.005999. PMID: 28862933

530. Chatterjee S, Davies MJ, Khunti K. Pharmaceutical Interventions for Diabetes Prevention in Patients at Risk. American Journal of Cardiovascular Drugs. Feb 2018; 18(1):13-24. doi: 10.1007/is40256-017-0239-y [Epub 31 Jul 2017]. PMID: 28762143

529. Mata-Cases M, Franch-Nadal J, Real J, Gratacos M, Lopez-Simarro F, Khunti K, Mauricio D. Therapeutic Inertia in Patients Treated with Two or More Antidiabetics in Primary Care: Factors Predicting Intensification of Treatment. Diabetes, Obesity and Metabolism. 2018 Jan;20(1):103-112. doi: 10.1111/dom.13045. [Epub 2017 Jul 28]. PMID: 28656746

528. Zaccardi F, Dhalwani NN, Davies MJ, Khunti K. Comment on: “Strengths and Limitations of Healthcare Databases in the Evaluation of Hypoglycaemia”. Diabetes, Obesity and Metabolism. 2017 Oct;19(10):1495-1496. doi: 10.1111/dom.13014. [Epub 2017 Jul 21] PMID: 28523737

527. McCarthy M, Edwardson CL, Davies MJ, Henson J, Rowlands A, King JA, Bodicoat D, Khunti K, Yates T. Breaking up sedentary time with seated upper body activity can regulate metabolic health in obese high risk adults: A randomised crossover trial. Diabetes Obes Metab. 2017 Dec;19(12):1732-1739. doi: 10.1111/dom.13016. [Epub 2017 Jul 20]. PMID:28544202

526. Kunutsor SK, Seidu S, Blom AW, Khunti K, Laukkanen JA. Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence. European Journal of Epidemiology. 2017 Aug;32(8):657-667. doi: 10.1007/s10654-017-0277-4. [Epub 2017 Jul 17]. PMID: 28718029

525. Sarwar KN, Cliff P, Saravanan P, Khunti K, Nirantharakumar K, Narendran P. Comorbidities, complications and mortality in people of South Asian ethnicity with type 1 diabetes compared with other ethnic groups: a systematic review. BMJ Open. 2017 Jul 13;7(7):e015005. doi: 10.1136/bmjopen-2016-015005 PMID:28710207

524. Bakrania K, Edwardson CL, Khunti K, Bandelow S, Davies MJ, Yates T. Associations between sedentary behaviours and cognitive function: cross-sectional and prospective findings from the UK Biobank. American Journal of Epidemiology. 2018 Mar 1;187(3):441-454. doi: 10.1093/aje/kwx273. [Epub 13 July 2017]. doi:10.1093/aje/kwx273. PMID: 28992036

523. Boels AM, Vos RC, Hermans T, Zuithoff N, Muller N, Khunti K, Rutten G; GUIDANCE study group. What determines treatment satisfaction of patients with type 2 diabetes on insulin therapy? An observational study in eight European countries. BMJ Open. 2017 Jul 11;7(7):e016180. doi: 10.1136/bmjopen-2017-016180. PMID: 28701411

522. Trivedi H, Gray LJ, Seidu S, Davies MJ, Charpentier G, Lindblad U, Kellner C, Nolan J, Pazderska A, Rutten G, Trento M, Khunti K. Self-knowledge of HbA1c in people with Type 2 Diabetes Mellitus and its association with glycaemic control. Primary Care Diabetes. 2017 Oct;11(5):414-420. doi: 10.1016/j.pcd.2017.03.011. [Epub 2017 Jul 3] PMID:28684227

521. Dunkley AJ, Tyrer F, Doherty Y, Martin-Stacey L, Patel N, Spong R, Makepeace C, Bhaumik S, Gangadharan SK, Yates T, Davies MJ, Khunti K, on behalf of the STOP Diabetes Team. Development of a multi-component lifestyle intervention for preventing type 2 diabetes and cardiovascular risk factors in adults with intellectual disabilities. Journal of Public Health (Oxf). 2017 Jun 17:1-10. doi: 10.1093/pubmed/fdx067 PMID: 28985308

520. Woringer M, Cecil E, Watt H, Chang K, Hamid F, Khunti K, Dubois E, Evason J, Majeed A, Soljak M. Evaluation of community provision of a preventative cardiovascular programme – the National Health Service Health Check in reaching the under-served groups by primary care in England: cross sectional observational study. BMC Health Services Research. 2017 Jun 14;17(1):405. doi: 10.1186/s12913-017-2346-5 PMID: 28615019

519. Hambling CE, Seidu SI, Davies MJ, Khunti K. Older people with type 2 diabetes, including those with Chronic Kidney Disease or dementia, are commonly overtreated on sulphonylurea or insulin therapies. Diabetic Medicine. 2017 Sep;34(9):1219-1227. doi: 10.1111/dme.13380. [Epub 2017 Jun 5] PMID: 28498634

518. Kidy FF, Dhalwani N, Harrington D, Gray LJ, Bodicoat D, Webb D, Davies MJ, Khunti K. Associations between anthropometric measurements and cardiometabolic risk factors in White European and South Asian adults in the UK. Mayo Clin Proc. 2017 Jun;92(6):925-933. doi: 10.1016/j.mayocp.2017.02.009 PMID: 28578782

517. Seidu S, Davies MJ, Farooqi A, Khunti K. Integrated primary care: Is this the solution to the diabetes epidemic? Diabetic Medicine. 2017 Jun;34(6):748-750. doi: 10.1111/dme.13348. PMID: 28294386

516. McCarthy M, Edwardson CL, Davies MJ, Henson J, Gray L, Khunti K, Yates T. Change in Sedentary Time, Physical Activity, Bodyweight, and HbA1c in High-Risk Adults. Med Sci Sports Exerc. 2017 Jun;49(6):1120-1125. doi: 10.1249/MSS.0000000000001218. PMID: 28121795

515. Dunkley AJ, Tyrer F, Gray LJ, Bhaumik S, Spong R, Chudasama Y, Cooper SA, Ganghadaran S, Davies MJ, Khunti K. Type 2 diabetes and glucose intolerance in a population with intellectual disabilities: the STOP diabetes cross-sectional screening study. Journal of Intellectual Disability Research. 2017 Jul;61(7):668-681. doi: 10.1111/jir.12380 [Epub 2017 May 21] PMID: 28544066

514. Kunutsor K, Seidu S, Khunti K. Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies. Eur Heart J. 2017 May 21;38(20):1608-1612. doi: 10.1093/eurheartj/ehx107. PMID: 28369602

513. Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen M, Thuresson M, Arya N, Bodegård J, Hammar N, Fenici P; CVD-REAL Investigators and Study Group. Lower Risk of Heart Failure and Death in Patients Initiated on SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study. Circulation. 2017 Jul 18;136(3):249-259. doi: 10.1161/CIRCULATIONAHA.117.029190. [Epub 2017 May 18] PMID: 28522450

512. Hadjiconstantinou M, Mani H, Patel N, Levy M, Davies MJ, Khunti K, Stone M. Understanding and supporting women with polycystic ovary syndrome: a qualitative study in an ethnically diverse UK sample. Endocrine Connections. 2017 Jul;6(5):323-330. doi: 10.1530?EC-17-0053 [Epub 2017 May 17] PMID: 28515051

511. Khunti K, Alsifri S, Aronson R, Cigrovski Berković M, Enters-Weijnen C, Forsén T, Galstyan G, Geelhoed-Duijvestijn P, Goldfracht M, Gydesen H, Kapur R, Lalic N, Ludvik B, Moberg E, Pedersen-Bjergaard U, Ramachandran A; HAT Investigator Group. Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes. Diabetes Research and Clinical Practice. 2017 Aug;130:121-129. doi: 10.1016/j.diabres.2017.05.004. [Epub 2017 May 12] PMID: 28602812

510. Danese M, Gleeson M, Kutikova L, Griffiths RI, Khunti K, Seshasai S, Ray K. Management of lipid-lowering therapy in patients with cardiovascular events in the UK: a retrospective cohort study. BMJ Open. 2017 May 10;7(5):e013851. doi: 10.1136/bmjopen-2016-013851. PMID: 28495810

509. Henson J, Yates T, Davies MJ, Khunti K. Type 2 diabetes preventions: A guide to management. Diabetes & Primary Care. May-June 2017; 19(3): 126-135.

508. Dunkley A, Tyrer F, Spong R, Gray LJ, Gillett M, Doherty Y, Martin-Stacey L, Patel N, Yates T, Bhaumik S, Chalk T, Chudasama Y, Thomas C, Sadler S, Cooper S, Gangadharan SK, Davies MJ, Khunti KScreening for glucose intolerance and development of a lifestyle education programme for prevention of type 2 diabetes in a population with intellectual disabilities: the STOP diabetes research project. NIHR Journals Library, Programme Grants Appl Res. May 2017;5(11). doi 10.3310/pgfar05110. PMID: 28671802

507. Kar D, Seidu S, Davies MJ, Khunti K. Managing vascular risk factors among obese quitters with diabetes: how intensive lifestyle intervention and novel pharmacotherapy can work in concert. Br J Diabetes. 2017;17(1):19-23 doi.org/10.15277/bjd.2017.120

506. Zaccardi F, Webb D, Davies MJ, Dhalwani N, Housley G, Shaw D, Hatton J, Khunti K. Risk factors and outcome differences in hypoglycaemia-related hospital admissions: A case-control study in England. Diabetes Obes Metab. 2017 Oct;19(10):1371-1378. doi: 10.1111/dom.12941. [Epub 2017 Apr 21] PMID: 28295974

505. O’Donovan G, Chudasama Y, Grocock S, Leigh R, Dalton A, Gray LJ, Yates T, Edwardson C, Hill S, Webb D, Khunti K, Davies MJ, Jones AP, Bodicoat DH, Wells A. The association between air pollution and type 2 diabetes in a large cross-sectional study in Leicester: The CHAMPIONS Study. Environ Int. 2017 Jul;104:41-47. doi: 10.1016/j.envint.2017.03.027. [Epub 2017 Apr 13] PMID: 28411585

504. Mauricio D, Meneghini L, Seufert J, Liao L, Wang H, Tong L, Cali A, Stella P, Carita P, Khunti K. Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA. Diabetes Obes Metab. 2017 Aug; 19(8):1155-1164. doi: 10.1111/dom.12927. [Epub 2017 Apr 10]. PMID: 28251792

503. Ji L, Bonnet F, Charbonnel B, Gomes M, Kosiborod M, Khunti K, Nicolucci A, Pocock S, Rathmann W, Shestakova M, Shimomura I, Watada H, Fenici P, Hammar N, Hashigami K, Macaraeg G, Surmont F, Medina J. Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program. J Diabetes Complications. 2017 Jul;31(7):1188-1196. doi: 10.1016/j.diacomp.201703.011. [Epub 2017 Apr 5] PMID: 28499961

502. Bakrania K, Yates T, Edwardson CL, Bodicoat DH, Esliger DW, Gill J, Kazi A, Velayudhan L, Sinclair AJ, Sattar N, Biddle S, Hamer M, Davies MJ, Khunti K. Associations of moderate-to-vigorous-intensity physical activity and body mass index with glycated haemoglobin within the general population: a cross sectional analysis of the 2008 Health Survey for England. BMJ Open. 2017 Apr 3;7(4):e014456. doi: 10.1136/bmjopen-2016-014456. PMID: 28373255

501. Dhalwani NN, Zaccardi F, O'Donovan G, Carter P, Hamer M, Yates T, Davies MJ, Khunti K. Association between lifestyle factors and the incidence of multimorbidity in an older English population. J Gerontol A Biol Sci Med Sci. 2017 Apr 1;72(4):528-534. doi: 10.1093/Gerona/glw146. PMID: 27470302

500. Khunti K, Mohan V, Jain SM, Boesgaard TW, Begtrup K, Sethi B. Efficacy and safety of IDegLira in participants with type 2 diabetes in India uncontrolled on oral antidiabetic drugs and basal insulin: Data from the DUAL clinical trial program. Diabetes Therapy. 2017 Jun;8(3):673-682. doi 10.1007/s13300-017-052.9. [Epub 2017 Mar 22] PMID:28332144

499. Zaccardi F, Webb D, Davies MJ, Dhalwani N, Gray LJ, Chatterjee S, Housley G, Shaw D, Hatton J, Khunti K. Predicting hospital stay, mortality, and readmission in people admitted for hypoglycaemia in England. Prognostic models derivation and validation. Diabetologia. 2017 Jun;60(6):1007-1015. doi: 10.1007/s00125-017-4235-1. [Epub 2017 Mar 17] PMID: 28314943

498. Paul SK, Owusu Adjah E, Samanta M, Patel K, Bellary S, Hanif W, Khunti K. Comparison of body mass index at diagnosis of diabetes in a multiethnic population: a case-control study with matched non-diabetic controls. Diabetes, Obesity and Metabolism. 2017 Jul;19(7):1014-1023. doi: 10.1111/dom.12915. [Epub 2017 Mar 17] PMID: 28211609

497. Webb DR, Zaccardi F, Davies MJ, Griffin SJ, Wareham NJ, Simmons RK, Rutten GE, Sandbaek A, Lauritzen T, Borch-Johnsen K, Khunti K. Cardiovascular risk factors and incident albuminuria in screen-detected type 2 diabetes. Diabetes Metabolism Research and Reviews. 2017 May;33(4). doi: 10.1002/dmrr.2877. [Epub 2017 Mar 2] PMID: 28029211

496. Gray LJ, Troughton J, Khunti K, Davies MJ. Let’s Prevent Diabetes: From idea to implementation. Practical Diabetes. 2017 March; 34(2): 55–57

495. Khunti K, Davies MJ. Clinical Inertia – time to reappraise the terminology? Primary Care Diabetes. 2017 Apr;11(2):105-106. doi:10.1016/j.pcd.2017.01.007. [Epub 2017 Feb 20] PMID: 28222959

494. Htike ZZ, Zaccardi F, Papamargaritis D, Webb DR, Khunti K, Davies MJ. Efficacy and Safety of Glucagon-like peptide-1 receptor agonists in type 2 diabetes Systematic review and mixed-treatment comparison analysis. Diabetes, Obesity and Metabolism. 2017 Apr;19(4):524-536. doi: 10.1111/dom.12849. [Epub 2017 Feb 17] PMID: 27981757

493. Chatterjee S, Khunti K, Davies MJ. Type 2 Diabetes. The Lancet. Jun 3;389(10085):2239-2251. doi: 10.1016/S0140-6736(17)30058-2 [Epub 2017 Feb 10] PMID: 28190580

492. Da Moura Semedo C, Webb M, Waller H, Khunti K, Davies MJ. Skin Autofluorescence, A Non-Invasive Marker of Advanced Glycation End Products: Clinical Relevance and Limitations. Postgrad Med J. 2017 May;93(1099):289-294. doi: 10.1136/postgradmedj-2016-134579. [Epub 2017 Jan 31] PMID: 28143896

491. Bakrania K, Edwardson CL, Khunti K, Henson J, Stamatakis E, Hamer M, Davies MJ, Yates T. Associations of objectively measured moderate-to-vigorous-intensity physical activity and sedentary time with all-cause mortality in a population of adults at high risk of type 2 diabetes mellitus. Preventive Medicine Reports. 2017 Jan 26;5:285-288. doi: 10.1016/j.pmedr.2017.01.013. PMID: 28149710

490. Gholap NN, Achana FA, Davies MJ, Ray KK, Gray LJ, Khunti K. Long-term mortality after acute myocardial infarction among individuals with and without diabetes: A systematic review and meta-analysis of studies in the post-reperfusion era. Diabetes Obes Metab. 2017 Mar;19(3):364-374. doi: 10.1111/dom.12827 [Epub 2017 Jan 19] PMID: 27862801

489. Biddle S, Edwardson CL, Gorely T, Wilmot EG, Yates T, Nimmo MA, Khunti K, Davies MJ. Reducing sedentary time in adults at risk of type 2 diabetes: process evaluation of the STAND (Sedentary Time ANd Diabetes) RCT. BMC Public Health. 14 Jan 2017; 17(1):80. doi: 10.1186/s12889-016-3941-9 PMID: 28088243

488. Valabhji J, Wareham N, Khunti K, Turner B, Smith J. Response to: ‘Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions’ [4 January 2017]. BMJ. 2017 13 January (Letter); 356:i6538 doi.org/10.1136/bmj.i6538

487. Kunutsor SK, Seidu S, Khunti K. Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis. The Lancet Haematology. 2017 Feb;4(2):e83-e93. [Epub 13 Jan 2017] doi: 10.1016/S2352-3026(16)30184-3 PMID: 28089655

486. Edwardson CL, Henson J, Bodicoat DH, Bakrania K, Khunti K, Davies MJ, Yates T. Associations of re-allocating sitting time into standing or stepping with glucose, insulin and insulin sensitivity: a cross sectional analysis of adults at risk of type 2 diabetes. BMJ Open. 2017 Jan 13;7(1):e014267. doi: 10.1136/bmjopen-2016-014267 PMID: 28087555

485. Carter P, Bodicoat DH, Jones A, Khunti K, Davies MJ, Edwardson CL, Henson J, Yates T, Coombes E. The impact of neighbourhood walkability on the effectiveness of a structured education programme to increase objectively measured walking. Journal of Public Health. 2018 March 1. 40(1): 82–89 doi: 10.1093/pubmed/fdw144. [Epub 9 Jan 2017] PMID: 28069992

484. Leal J, Ahrabian D, Davies MJ, Gray LJ, Khunti K, Yates T, Gray AM. Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let’s Prevent Diabetes cluster-randomised controlled trial. BMJ Open. 2017 Jan 9;7(1):e013592. doi: 10.1136/bmjopen-2016-013592 PMID: 28069625

483. Henson J, Yates T, Davies MJ, Khunti K. Unit 3 special care groups type 2 diabetes prevention: A guide to management. Diabetes and Primary Care. 19(3):126-134 [01 Jan 2017].

482. Davies MJ, Gray LJ, Ahrabian D, Carey M, Farooqi A, Gray A, Goldby S, Hill S, Jones K, Leal J, Realf K, Skinner T, Stribling B, Troughton J, Yates T, Khunti K; on behalf of the Let’s Prevent Diabetes Team. A community-based primary prevention programme for type 2 diabetes mellitus integrating identification and lifestyle intervention for prevention: a cluster randomised controlled trial. Programme Grants for Applied Research. 5(2) January 2017. ISSN 2050-4322 doi: 10.3310/pgfar05020 PMID: 28121091

481. Gates A, Khunti K. How to use the “Movement for Movement” resources, 2017 update. Resource Contributor.

You can also view a PDF of my 2015 publications and 2016 publications.

Research

    Professional interest in quality improvement, especially in cardiovascular disease and diabetes, and in teaching

    Interest in evidence-based medicine and audit

    Interest in cardiovascular medicine and diabetes

Projects

Supervision

Current students

Dan Lane September 2018 –
University of Leicester, jointly with Professor Khunti, Dr Pankaj Gupta and Professor Donald Jones, Diabetes Research Centre
Developments of biochemical methods to diagnose non-adherence in cardiometabolic diseases and their clinical utility

Elpida Vounzoulaki September 2018 –
University of Leicester, jointly with Professor Khunti, Dr Clare Gillies and Professor Bee Tan, Diabetes Research Centre
Type 2 diabetes in women after a diagnosis of gestational diabetes: understanding uptake to screening, progression rates and costs, using evidence synthesis methodologies

Cameron Razieh October 2017 –
University of Leicester, with Professor Khunti, Diabetes Research Centre
Reducing ethnic health inequalities: Exercise for health promotion in South Asians

Humaira Hussein September 2017 –
University of Leicester, with Professor Khunti, Diabetes Research Centre
Comparative effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in type 2 diabetes mellitus: randomized and real-word evidence

Yogini Chudasama January 2017 –
University of Leicester, with Professor Khunti, Diabetes Research Centre
Multimorbidity, lifestyle behaviours, and life expectancy

Usman Muhammad September 2016 -
University of Leicester, jointly with Professor Khunti, Professor Davies and Dr Tom Yates, Diabetes Research Centre.
Effects of intensive interventions in individuals with type 2 diabetes and microalbuminuria

Share this page: